Tech Company Financing Transactions
Accent Therapeutics Funding Round
Atlas Venture, EcoR1 Capital Management and The Column Group joined a $40 million Series A capital raise for Accent Therapeutics. The round was announced on 5/19/2018.
Transaction Overview
Company Name
Announced On
5/19/2018
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Proceeds Purpose
Company establishes platform strategy to lead development of promising new precision therapies in the emerging field of epitranscriptomics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
65 Hayden Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shakti Narayan
Chief Financial Officer
Nicole Heifner
President
Robert Copeland
Vice President
Ann Boriack-Sjodin
Vice President
Kenneth Duncan
Vice President
Scott Ribich
VP - Bus. Development
David Brower
Browse more venture capital transactions:
Prev: 5/19/2018: Simple Contacts venture capital transaction
Next: 5/19/2018: REBBL venture capital transaction
Share this article
About Database of VC Transactions
We record funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs